| PEMGX | WENRX | PEMGX / WENRX | |
| Total Expense Ratio | 0.91 | 0.80 | 114% |
| Annual Report Gross Expense Ratio | 0.91 | 0.81 | 112% |
| Fund Existence | 20 years | 11 years | - |
| Gain YTD | 2.065 | 15.050 | 14% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 31.6B | 646M | 4,892% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -7.41 | -1.77 | 419% |
| Returns for 3 years | 32.06 | 42.64 | 75% |
| Returns for 5 years | 25.07 | -20.33 | -123% |
| Returns for 10 years | 94.30 | 41.23 | 229% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 32.75 | 0.38 | +1.18% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| AIRR | 98.68 | 1.01 | +1.03% |
| First Trust RBA Amer Indl RenaisTM ETF | |||
| VLU | 210.46 | 1.45 | +0.69% |
| State Street® SPDR® S&P® 1500 ValTiltETF | |||
| IHYF | 22.67 | 0.05 | +0.22% |
| Invesco High Yield Bond Factor ETF | |||
| CPRJ | 26.67 | 0.05 | +0.20% |
| Calamos Russell 2000 Str Alt Prt ETF-Jul | |||